Clinical Trials Logo

Wound clinical trials

View clinical trials related to Wound.

Filter by:

NCT ID: NCT05297721 Completed - Nurse's Role Clinical Trials

Nurses' Level of Knowledge on Skin Tears: A Cross-Sectional Study

Start date: September 1, 2021
Phase:
Study type: Observational [Patient Registry]

Skin tears (ST) are one of the skin integrity problems encountered in healthcare settings with rates equal to or greater than pressure injuries. However, the importance of this problem has been emphasized in the literature in recent years. This study was conducted to determine the knowledge level of nurses about ST.

NCT ID: NCT05183698 Not yet recruiting - Wound Clinical Trials

Point-spectroscopy Trial

Start date: January 10, 2022
Phase:
Study type: Observational

Evaluation and characterization of autofluorescence signals of tissue in and around wounds as identified by MolecuLight fluorescence image.

NCT ID: NCT05054244 Recruiting - Quality of Life Clinical Trials

Clinical Implications of Biofilm in Chronic Wound

Start date: July 1, 2021
Phase:
Study type: Observational

Chronic wounds are important economic and health-care problem. Biofilm has been recognized as a major factor in wound chronicity, delayed healing, and persistent infections, increasing the need for frequent dressing changes, painful debridement and systemic antimicrobial treatments influencing quality of life. In the presence of "un-cultivating" bacteria and limitations of clinical indicators of biofilm presence, there is a need for simple "screening" diagnostic method for biofilm detection. Chronic wounds of different etiology often associated with chronic pain reduce working abilities and cause restrictions in everyday living diminishing patient's quality of life. Efficacy of hyperbaric oxygenation therapy (HBOT) in treating chronic wound and associated infection has been suggested. This observational prospective cohort study will be conducted at the Department of undersea and hyperbaric medicine and Department of dermatovenereology, Clinical Hospital Center Rijeka during 3-year period from 2021. to 2024. including all patients treated due to chronic wound irrespective of the ethology. The patients will be evaluated upon enrolment, after 2, 4, 6 weeks, and 3, 6, 9, 12 months period, to clinically evaluate the wound characteristics, evaluate clinical healing rate, clinical indicators of biofilm and/or infection, need for additional diagnostic or treatment procedures. The patients in both groups (control and HBOT group) will be treated with standard treatment (dressings, debridement, antibiotics, infection control), in addition HBOT sessions will be performed (HBOT group). Impact of chronic wound and both treatment options to patient related outcome measures will be evaluated assessing intensity and pain characteristics, quality of life, depression, and anxiety by means of standardized questionnaires (visual analogue scale, McGill Pain questionnaire, Wound Quality of Life Index, Health Quality of Life Questionnaire, Beck depression and anxiety inventory). Microbiological analyses of swabs/biopsies will be evaluated to determine microbial profile and resistance. Detection and objectivization of biofilm will be evaluated by standard methods on microbiological isolates (Congo red agar, tube method, tissue culture plate method) and confocal scanning laser microscopy, and on clinical samples by light microscopy. Primary and secondary objective will be assessed after 1 year follow-up.

NCT ID: NCT05045430 Recruiting - Wound Clinical Trials

PMS Study to Confirm the Ongoing Safety and Performance of Silver II Non-woven Dressing in Chronic and Acute Wounds

Start date: July 13, 2022
Phase: N/A
Study type: Interventional

Post Market Surveillance Study to confirm the safety and performance of Silver II Non-Woven Dressing in Chronic and Acute Wounds

NCT ID: NCT05007301 Active, not recruiting - Diabetic Foot Ulcer Clinical Trials

Geko™ Cross Therapy Registry - Wound

CTR-Wound
Start date: April 4, 2022
Phase:
Study type: Observational [Patient Registry]

The geko™ Cross Therapy REGISTRY - Wound is a prospective, observational, anonymised data collection Registry with no experimental treatment that will fulfil an unmet need for an observational Registry to provide long-term clinical data to demonstrate patient benefit and regulatory compliance.

NCT ID: NCT04997863 Not yet recruiting - Wound Clinical Trials

Clinical Efficacy and Safety of Sericin Hydrogel Sheet Impregnated With Bird's Nest Extract

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Split-thickness skin graft (STSG) is one of the most common procedures performed in plastic surgery and dermatology. The donor site of skin grafting is expected to heal without scarring. However, hypertrophic scar formation is prevalent among STSG donor sites during scar maturation and has become a significant problem at present. Hypertrophic scar results in aesthetic, physical, functional, and psychological problems, leading to a dramatic impact on patients' quality of life ultimately. There are many current therapeutic approaches for preventing and treating hypertrophic scars; however, they remain clinically unsatisfactory because many treatments have been associated with high recurrent rates, high cost, and side effects. Currently, there are no gold standards for hypertrophic scar therapy. There are many attempts to develop new treatment options for the prevention and management of scarring that are acceptable to both physicians and patients. It has previously been shown that both edible bird's nest (EBN) extract and sericin have effectiveness in reducing scar development. They might be a suitable alternative option for scar prevention and could be used safely. Therefore, the sericin hydrogel sheet impregnated with EBN extract is developed as it is believed that the synergism of these combined compounds would be a great help to prevent the development of scars. This study aims to evaluate the efficacy and safety of sericin hydrogel sheet impregnated with EBN extract for the prevention of scar formation in patients with STSG donor sites.

NCT ID: NCT04890769 Terminated - Wound Clinical Trials

Clinical Study of Moisture Sensor Dressing Used for Exuding Wounds

Start date: May 21, 2021
Phase:
Study type: Observational

Observational prospective study of the clinical use of a wound dressing with a moisture sensor for use on exuding wounds.

NCT ID: NCT04731753 Completed - Wound Clinical Trials

PMCF Study to Examine the Debridement Pad Cutimed DebriClean

Start date: April 27, 2021
Phase:
Study type: Observational

Documentation of the performance and safety of the debridement pad Cutimed DebriClean in daily clinical practice

NCT ID: NCT04701632 Active, not recruiting - Wound Clinical Trials

Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool

Start date: October 28, 2019
Phase:
Study type: Observational

The objective of the study is to complete a retrospective chart review of subjects who were treated at the Wound Care Clinic at Methodist Dallas Medical Center, presented for treatment between June 2018 and February 2019, and were administered the PHQ-9. The study aims to measure the prevalence of depression in this sample, feasibility of using PHQ-9 in this patient population, and identifying variables and functional impairment associated with clinically significant depression.

NCT ID: NCT04677166 Recruiting - Burns Clinical Trials

Coupling Negative Pressure Wound Therapy With Instillation

Start date: January 19, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to compare standard negative pressure wound therapy with negative pressure wound therapy coupled with instillation for optimal skin graft take. Either the V.A.C ULTA NPWT or V.A.C. VeraFlo Therapy systems with normal saline will be applied intra-operatively to split-thickness skin grafts of upper and lower extremity wounds and kept in place for a duration of four days. Following completion of four days, the skin graft with be assessed for percentage of take/adherence and will be covered with simple gauze dressings as needed.